126 related articles for article (PubMed ID: 3566842)
1. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl]propionic acid. 4th communication: inhibitory effects on rat adjuvant arthritis.
Tsurumi K; Kokuba S; Okada K; Yanagihara M; Fujimura H
Arzneimittelforschung; 1986 Dec; 36(12):1810-7. PubMed ID: 3566842
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 1st communication: inhibitory effects of rat paw edema.
Tsurumi K; Kyuki K; Niwa M; Kokuba S; Fujimura H
Arzneimittelforschung; 1986 Dec; 36(12):1796-800. PubMed ID: 3566840
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions.
Tsurumi K; Kyuki K; Niwa M; Mibu H; Fujimura H
Arzneimittelforschung; 1986 Dec; 36(12):1801-5. PubMed ID: 3105545
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 5th communication: antiplatelet effect of the drug and antiinflammatory effect of its main metabolite.
Tsurumi K; Kyuki K; Yanagihara M; Hasegawa J; Fujimura H
Arzneimittelforschung; 1986 Dec; 36(12):1818-22. PubMed ID: 3566843
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 3rd communication: inhibitory effects on leucocyte emigration and proliferation of granulation.
Tsurumi K; Mibu H; Okada K; Hasegawa J; Fujimura H
Arzneimittelforschung; 1986 Dec; 36(12):1806-9. PubMed ID: 3566841
[TBL] [Abstract][Full Text] [Related]
6. Analgesic and antiinflammatory effects of 2-(10,11-dihydro-10-oxo-dibenzo[b,f]thiepin-2-yl)propionic acid in rat and mouse.
Kameyama T; Nabeshima T; Yamada S; Sato M
Arzneimittelforschung; 1987 Jan; 37(1):19-26. PubMed ID: 3494460
[TBL] [Abstract][Full Text] [Related]
7. Rat adjuvant arthritis as a model to test potential antirheumatic agents.
Toivonen ML; Tokola O; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1982; 4(6):359-63. PubMed ID: 7144330
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and immunomodulating effects of the novel agent gamma-(2-aminoethylamino)-2-butyrothienone. 2nd communication: inhibitory effect on rat adjuvant induced disease.
Kourounakis L; Gavalas A; Karagouni EE; Litina D; Kourounakis P
Arzneimittelforschung; 1991 May; 41(5):537-41. PubMed ID: 1898425
[TBL] [Abstract][Full Text] [Related]
9. Effect of a novel anti-inflammatory drug, 2-(10, 11-dihydro-10-oxo-dibenzo[b,f]-thiepin-2-yl)propionic acid (CN-100), on the proteoglycan biosynthesis in articular chondrocytes and prostaglandin E2 production in synovial fibroblasts.
Ito A; Mori Y
Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):131-42. PubMed ID: 2177561
[TBL] [Abstract][Full Text] [Related]
10. A new protein antidenaturant agent, bindarit, reduces secondary phase of adjuvant arthritis in rats.
Cioli V; Ciarniello MG; Guglielmotti A; Luparini MR; Durando L; Martinelli B; Catanese B; Fava L; Silvestrini B
J Rheumatol; 1992 Nov; 19(11):1735-42. PubMed ID: 1491393
[TBL] [Abstract][Full Text] [Related]
11. Optical resolution and absolute configuration of a nonsteroidal antiinflammatory drug, 2-(10,11-dihydro-10-oxodibenzo- [b,f]thiepin-2-yl)propionic acid.
Yamamoto M; Masaki M; Nohira H
Chirality; 1990; 2(4):280-3. PubMed ID: 2083151
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profiles of 2-carboxyphenyl-1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate and 2-[(2-carboxyphenoxy)-carbonyl]phenyl-1-(4-chlorobenzoyl)-5-meth oxy-2- methylindole-3-acetate, new antiinflammatory agents.
Tanaka I; Yoshizumi H; Tanaka Y; Takeda S; Kamei C; Nakaya N; Kitazumi K; Tagami H; Tasaka K
Arzneimittelforschung; 1986 Apr; 36(4):703-9. PubMed ID: 3487327
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic anti-inflammatory properties of [2,2-dimethyl-6-(4- chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid.
Laufer S; Tries S; Augustin J; Elsässer R; Albrecht W; Guserle R; Algate DR; Atterson PR; Munt PL
Arzneimittelforschung; 1995 Jan; 45(1):27-32. PubMed ID: 7893265
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5-trifluoromethyl-4,5-dihydro-1H-pyrazoles on chronic inflammatory pain model in rats.
Sauzem PD; Sant'Anna Gda S; Machado P; Duarte MM; Ferreira J; Mello CF; Beck P; Bonacorso HG; Zanatta N; Martins MA; Rubin MA
Eur J Pharmacol; 2009 Aug; 616(1-3):91-100. PubMed ID: 19540223
[TBL] [Abstract][Full Text] [Related]
15. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
16. Effect of immunostimulatory ribomunyl on the preventive treatment of rat adjuvant arthritis with cyclosporine and methotrexate.
Rovensky J; Svík K; Stancíková M; Istok R
J Rheumatol; 2003 Sep; 30(9):2027-32. PubMed ID: 12966611
[TBL] [Abstract][Full Text] [Related]
17. Antiinflammatory activities of copper-aspirinate and aspirin in adjuvant arthritic rats.
Kishore V
Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):257-60. PubMed ID: 3393733
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease.
Avramidis N; Kourounakis A; Hadjipetrou L; Senchuk V
Arzneimittelforschung; 1998 Jul; 48(7):764-71. PubMed ID: 9706378
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytogenin, a novel anti-arthritic agent, on type II collagen-induced arthritis in DBA/1J mice and adjuvant arthritis in Lewis rats.
Hirano S; Wakazono K; Agata N; Mase T; Yamamoto R; Matsufuji M; Sakata N; Iguchi H; Tone H; Ishizuka M
Int J Tissue React; 1994; 16(4):155-62. PubMed ID: 7797401
[TBL] [Abstract][Full Text] [Related]
20. The pharmacological properties of fenbufen. A review.
Sloboda AE; Tolman EL; Osterberg AC; Panagides J
Arzneimittelforschung; 1980; 30(4A):716-21. PubMed ID: 7002162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
